Results 151 to 160 of about 7,425,127 (300)

Discordance in Treatment Response Assessment Between Clinicians and Patients With Skin Chronic Graft-vs-Host Disease. [PDF]

JAMA Dermatol
Babu V, Shin DB, Onstad L, Pidala JA, Chen G, Lee CJ, Kitko CL, Carpenter PA, Cutler C, El Jurdi N, Loren AW, Gelfand JM, Lee SJ, Baumrin E.   +13 more
europepmc   +1 more source

Beyond antimicrobials: Ecological nano‐strategies for rebalancing dysbiotic oral microbial homeostasis

BMEMat, EarlyView.
Oral microbial homeostasis, a dynamic host‐microbe balance, is vital in infectious diseases. Conventional antibiotics often disrupt this homeostasis, spurring interest in nanomaterials for oral microbial homeostasis rebalancing. This review outlines nanomaterial strategies across three ecological levels (population/community, ecosystem, and cross ...
Chen Hu, Aohan Luan, Yujun Yang, Linlin Wang, Huilin Wang, Ning Wang, Guixin He, Yajie Yang, Rabiya Noor, Jawad Hussain, Longquan Shao   +10 more
wiley   +1 more source

Editorial: Langerhans Cells and How Skin Pathology Reshapes the Local Immune Environment

Frontiers in Immunology, 2019
Clare L. Bennett, Carrie A. Ambler
doaj   +1 more source

Evaluation of cyclophosphamide for steroid-refractory hepatic acute graft-vs-host disease after allogeneic hematopoietic stem cell transplantation. [PDF]

Front Immunol
Lu N, Zheng Y, Guo W, Zheng X, Feng D, Cao Y, Zhang R, Zhai W, Yang D, Wei J, He Y, Pang A, Feng S, Han M, Jiang E.   +14 more
europepmc   +1 more source

Post-Transplant Cyclophosphamide for the Prevention of Graft-vs.-Host Disease in Allogeneic Hematopoietic Cell Transplantation: A Guide to Management for the Advanced Practitioner. [PDF]

J Adv Pract Oncol, 2023
Kachur E, Patel JN, Morse AL, Moore DC, Arnall JR.   +4 more
europepmc   +1 more source

Ocular manifestations of graft-versus-host disease: 10 years’ experience

, 2015
Xihui Lin, Harrison Dwight Cavanagh Department of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, TX, USA Purpose: To evaluate the ocular presentation, treatment, and clinical course of graft-versus-host disease (GVHD).
Cavanagh HD, Lin X
core  

Digital workflow to assess healing after acellular dermal matrix exposure in root coverage: A case report

Clinical Advances in Periodontics, EarlyView.
Abstract Background This case report describes 18‐month clinical and digital outcomes after bilateral treatment of multiple gingival recessions using coronally advanced flap plus acellular dermal matrix (ADM). Methods A 46‐year‐old woman with multiple maxillary recessions received bilateral surgery.
Edgar Daniel Vargas‐Quiroga, Ana Carolina Duarte Firmino, Débora S. F. Sávio, Rhayssa Tritula Barini, Juliana Jendiroba Faraoni, Mario Taba‐Jr, Bruna S. H. Tonin, Arthur Belém Novaes Junior   +7 more
wiley   +1 more source

Clinical characteristics and risk factors of acute cutaneous graft-vs.-host disease following allogeneic hematopoietic stem cell transplantation in pediatric acute myeloid leukemia: a single-center retrospective study. [PDF]

Front Pediatr
He S, Zheng M, Kuang W, Song N, Deng S, Zhang B.   +5 more
europepmc   +1 more source

Multimodal Fluorescent MOF@BODIPY Platform: Bridging Sensing and Mechanistic Insight

Chemistry – A European Journal, EarlyView.
ABSTRACT Hybrid metal–organic frameworks (MOFs) that integrate organic chromophores constitute powerful platforms for optical sensing by combining structural order with tunable photophysics. Incorporating photoresponsive chromophores into MOFs enables sensitive probing of guest–framework interactions through well‐defined luminescent signatures. Herein,
Alejandro Cortés‐Villena, Paula Rodrigo‐Martínez, José A. Sáez, Pablo Gaviña, Emilio Pardo, Raquel E. Galian, Sergio Armenta, Héctor Martínez‐Pérez‐Cejuela, José Manuel Herrero‐Martínez   +8 more
wiley   +1 more source

Clinical Model‐Informed Precision Dosing Consult Service for Accelerating Personalized Medication in Pediatric Patients

Clinical Pharmacology &Therapeutics, EarlyView.
Traditional dosing strategies often rely on a “one‐size‐fits‐all” paradigm, assuming an “average” patient with typical demographic and pharmacological characteristics. In reality, this often overlooks existing between‐patient variability and can lead to suboptimal drug exposure or toxicity. This issue is especially pronounced in pediatric patients, who
Zachary L. Taylor, Takanobu Nadai, Kei Irie, Wen Rui Tan, Sanjana Parikh, Anhar Hosawi, Matthijs W. van Hoogdalem, Ronaldo Morales Junior, Sonya Tang Girdwood, Abbie D. Leino, Kana Mizuno, Alexander A. Vinks, Tomoyuki Mizuno   +12 more
wiley   +1 more source